Korro Bio, Inc. (KRRO) KPIs and segments

KRRONasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/30

$13.61−0.70 (-4.89%)

Close on Nov 13, 2026Market cap $200.42MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Korro Bio's business

Coming soon

This tab will track the numbers specific to Korro Bio's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?